Antibe Therapeutics boosts non-brokered private positioning to a complete of 2.

Antibe Therapeutics boosts non-brokered private positioning to a complete of 2.27 million units Antibe Therapeutics Inc apotek journal . announces an increase to how big is its non-brokered private positioning to a total of approximately 2.27 million units at a price of $0.55 per Unit, from the previously announced total of around 1.8 million Units, each Device made up of one Common Share of the organization and one-half of 1 Common Share purchase warrant with each whole Warrant entitling the holder to purchase an additional Common Share at a price of $0.80 per Warrant Share for a term of thirty-six months following time of issuance, for gross proceeds of up to $1.25 million .